Truist Financial Reiterates “Buy” Rating for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNH)‘s stock had its “buy” rating reissued by Truist Financial in a research report issued to clients and investors on Wednesday, Benzinga reports. They currently have a $600.00 target price on the healthcare conglomerate’s stock. Truist Financial’s price objective would indicate a potential upside of 21.66% from the company’s current price.

UNH has been the topic of a number of other research reports. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 10th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research report on Thursday, April 4th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Royal Bank of Canada reiterated an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 29th. Finally, Oppenheimer reissued an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Four analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $569.68.

UnitedHealth Group Trading Up 3.0 %

Shares of UnitedHealth Group stock opened at $493.16 on Wednesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The stock has a market cap of $454.66 billion, a PE ratio of 30.14, a PEG ratio of 1.28 and a beta of 0.54. UnitedHealth Group has a 52-week low of $436.38 and a 52-week high of $554.70. The firm has a 50-day moving average of $488.97 and a 200-day moving average of $515.22.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.26 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group will post 27.75 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

Several institutional investors have recently bought and sold shares of UNH. Robbins Farley bought a new position in UnitedHealth Group in the 3rd quarter valued at $25,000. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $26,000. CGC Financial Services LLC lifted its position in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the last quarter. True Wealth Design LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $31,000. Finally, NewSquare Capital LLC lifted its position in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.